Craig Adam R

VP and Chief Medical Officer at CytRx Oncology Corp · on record since Jun 30, 2006
Director at X4 Pharmaceuticals, Inc · on record since Aug 14, 2025
Executive Chairman at X4 Pharmaceuticals, Inc · on record since Aug 14, 2025
EVP, Development & CMO at Viracta Therapeutics, Inc. · on record since Mar 2, 2012
Director at CTI BIOPHARMA CORP · on record since Mar 21, 2017
President and CEO at CTI BIOPHARMA CORP · on record since Oct 3, 2017

Insider trading activity of Craig Adam R

Transactions on record: 109; since Jun 30, 2006

Open-market buys: 4; $282.8K

Open-market sells: 26; $5.3M

Companies traded: 4; last filing Aug 13, 2026

Figures computed from official regulatory filings — .

Companies where Craig Adam R has traded

X4 Pharmaceuticals, Inc6 tx · $460.8K · Aug 13, 2026
CTI BIOPHARMA CORP86 tx · $6.1M · Jun 26, 2023
Viracta Therapeutics, Inc.8 tx · $38.9K · Mar 2, 2015
CytRx Oncology Corp9 tx · $540.9K · Jul 23, 2007

Track record of Craig Adam R

Statistical track record

Free account

Open-market buys: 5

Last buy: Oct 23, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Craig Adam R

Co-insiders of Craig Adam R

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
X4 Pharmaceuticals, IncListing on record	Aug 13, 2026	Sell	-47,436	4.44 USD	$210.8K		SEC
X4 Pharmaceuticals, IncListing on record	Oct 31, 2025	AwardD (derivative)	2,329,154	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Oct 27, 2025	Buy	86,206	2.90 USD	$250K	conv 65Unusual sizeFirst in 12mo	SEC
X4 Pharmaceuticals, IncListing on record	Aug 14, 2025	AwardD (derivative)	1,609,873	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Aug 14, 2025	Award	289,881	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Aug 14, 2025	AwardD (derivative)	529,201	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-1,115,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	Other	-31,470	9.10 USD	$286.4K	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-2,320,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-470,054	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-475,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-450,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-1,200,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-600,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-900,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-800,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Mar 16, 2023	AwardD (derivative)	900,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	Sell	-2,117	6.01 USD	$12.7K		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	Exercise	2,117	0.84 USD	$1.8K		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	Exercise	83,200	0.84 USD	$69.9K		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	Sell	-83,200	6.00 USD	$499.2K		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	ExerciseD (derivative)	-83,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	ExerciseD (derivative)	-2,117	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jan 3, 2023	ExerciseD (derivative)	-84,683	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jan 3, 2023	Sell	-700	6.01 USD	$4.2K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
X4 Pharmaceuticals, IncListing on record	Aug 13, 2026	Sell	-47,436	4.44 USD	$210.8K		SEC
X4 Pharmaceuticals, IncListing on record	Oct 31, 2025	AwardD (derivative)	2,329,154	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Oct 27, 2025	Buy	86,206	2.90 USD	$250K	conv 65Unusual sizeFirst in 12mo	SEC
X4 Pharmaceuticals, IncListing on record	Aug 14, 2025	AwardD (derivative)	1,609,873	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Aug 14, 2025	Award	289,881	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Aug 14, 2025	AwardD (derivative)	529,201	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-1,115,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	Other	-31,470	9.10 USD	$286.4K	Unusual size	SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-2,320,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-470,054	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-475,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-450,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-1,200,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-600,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-900,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-800,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Mar 16, 2023	AwardD (derivative)	900,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	Sell	-2,117	6.01 USD	$12.7K		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	Exercise	2,117	0.84 USD	$1.8K		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	Exercise	83,200	0.84 USD	$69.9K		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	Sell	-83,200	6.00 USD	$499.2K		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	ExerciseD (derivative)	-83,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jan 26, 2023	ExerciseD (derivative)	-2,117	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jan 3, 2023	ExerciseD (derivative)	-84,683	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jan 3, 2023	Sell	-700	6.01 USD	$4.2K		SEC